BetaEntity Annotation Prototype
← Back to institutions

Annotated abstract

Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial

bmj · 2025-11-03 · canonical JSON source

1 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

The data sharing statement in this paper by Fang and colleagues (BMJ 2025;389:e085680, doi:10.1136/bmj-2025-085680, published 5 June 2025) has been updated as the authors have deposited their data in a different platform.